
Deborah McElhone, head of sustainability pharma at the Centre for Process Innovation (CPI), discusses the partnership between India and the UK.
The UK’s National Health Service (NHS) is targeting net zero with its Scope1, 2 and 3 emissions by 2045. Given the global nature of pharmaceutical supply chains and the fact that 25% of medicines dispensed in the UK are sourced from India, addressing this target requires collaborative efforts on a worldwide scale.
Although India has set ambitious sustainability targets, including commitments to achieve net zero emissions by 2070, these…